| __timestamp | Arrowhead Pharmaceuticals, Inc. | Perrigo Company plc |
|---|---|---|
| Wednesday, January 1, 2014 | 175000 | 1447700000 |
| Thursday, January 1, 2015 | 382000 | 1712400000 |
| Friday, January 1, 2016 | 158333 | 2051800000 |
| Sunday, January 1, 2017 | 31407709 | 1979500000 |
| Monday, January 1, 2018 | 16142321 | 1831500000 |
| Tuesday, January 1, 2019 | 168795577 | 1773300000 |
| Wednesday, January 1, 2020 | 87992066 | 1815200000 |
| Friday, January 1, 2021 | 138287000 | 1416200000 |
| Saturday, January 1, 2022 | 232810000 | 1455400000 |
| Sunday, January 1, 2023 | 240735000 | 1680400000 |
| Monday, January 1, 2024 | 3551000 |
Data in motion
In the ever-evolving pharmaceutical landscape, understanding financial health is crucial. This analysis delves into the gross profit trends of Perrigo Company plc and Arrowhead Pharmaceuticals, Inc. from 2014 to 2023. Perrigo, a stalwart in the industry, consistently outperformed Arrowhead, with gross profits peaking at approximately $2 billion in 2016. In contrast, Arrowhead's profits, though modest, showed a remarkable growth trajectory, surging by over 137,000% from 2014 to 2023. Notably, 2023 marked Arrowhead's highest gross profit, reaching nearly $241 million, a testament to its strategic advancements. However, data for 2024 remains incomplete, highlighting the dynamic nature of financial forecasting. This comparative analysis underscores the diverse strategies and market positions of these two companies, offering valuable insights for investors and industry enthusiasts alike.
Who Generates Higher Gross Profit? Amgen Inc. or Perrigo Company plc
Gilead Sciences, Inc. vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing United Therapeutics Corporation and Perrigo Company plc
BioMarin Pharmaceutical Inc. and Arrowhead Pharmaceuticals, Inc.: A Detailed Gross Profit Analysis
Ascendis Pharma A/S vs Arrowhead Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Perrigo Company plc vs Travere Therapeutics, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Perrigo Company plc and BioCryst Pharmaceuticals, Inc.
Key Insights on Gross Profit: Perrigo Company plc vs MiMedx Group, Inc.
Who Generates Higher Gross Profit? MorphoSys AG or Arrowhead Pharmaceuticals, Inc.
Gross Profit Trends Compared: Arrowhead Pharmaceuticals, Inc. vs Amphastar Pharmaceuticals, Inc.
Key Insights on Gross Profit: Arrowhead Pharmaceuticals, Inc. vs Taro Pharmaceutical Industries Ltd.
Arrowhead Pharmaceuticals, Inc. vs Evotec SE: A Gross Profit Performance Breakdown